Type 1 Diabetes Information Center
Insulin pump therapy is linked to lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than insulin injection therapy.
However, long-term type 1 diabetes is associated with hand pain, disability, and stiffness.
A 36-year-old man with type 1 diabetes presents to the emergency room with hyperglycemia and possible diabetic ketoacidosis after not taking his insulin for 3 days.
The FDA approves an "artifical pancreas" for patients over 14 years of age.
Pediatric patients with type 1 diabetes often have low levels of vitamin D.
The ADA has published the 2016 Standards of Medical Care in Diabetes that outline the best practices for diabetes care and management.
Intranasal glucagon is noninferior to intramuscular glucagon in adults with type 1 diabetes.
While undergoing physical therapy after a stroke, a patient with type 1 diabetes has a hypoglycemia-related stroke.
Research shows that adding metformin to insulin therapy will not boost glycemic control in overweight teens with type 1 diabetes.
For people with type 1 diabetes, using insulin pump therapy lowers mortality from all causes.